ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 268965 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 268965; 2) Community: the network communities that were significantly associated with the response to NSC 268965; 3) Molecule: the relationships between components within communities and NSC 268965; 4) MDR: the compounds that were significantly associated with the NSC 268965.

NSC Compound Enrichment Correlation
NSC 700455 Quinoline-3,3,4,4-tetracarbonitrile, 2-(4-bromophenyl)-1,2,3,4,5,6,7,8-octahydro- 0.017498903403062 0.17164446
NSC 710895 3-[(1H-Indol-3-ylethyl)amino]-2-(3-isopropoxyphenyl)-2H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxide 0.017498903403062 0.091276895
NSC 722781 trans-bis(acetato)amminepyridineplatinum(II) 0.017498903403062 0.28012537
NSC 740 Methotrexate 0.017498903403062 0.22707818
NSC 268993 Deferoxamine hydrochloride 0.0178844438004194 0.48368865
NSC 305799 2,4-Quinazolinediamine, 6-[[4-(dimethylamino)phenyl]thio]- 0.0178844438004194 0.15339928
NSC 636092 Pyridine-3,5-dicarboxamide, 1,4-dihydro-2,6-dimethyl- 4-[4-(dimethylamino)phenyl]-N,N'-diphenyl- 0.0178844438004194 -0.016579823
NSC 645253 Null 0.0178844438004194 0.45741109
NSC 649677 Null 0.0178844438004194 0.49845434
NSC 651774 Null 0.0178844438004194 0.21269862
Total:50  Current:17    [First] [Prev] [Next] [Last]